Body Weight

Among adults with type 2 diabetes, inhaled insulin was associated with HbA1c reductions similar to those with insulin aspart, fewer hypoglycemic episodes and lower body weight, according to a study published in Endocrine Practice.

Within couples, there was often similar adherence or nonadherence to ideal CV health behaviors, which may represent an opportunity for targeted risk factor modification, researchers reported.

Adults with poorly controlled type 2 diabetes assigned higher, investigational doses of the GLP-1 receptor agonist dulaglutide experienced greater improvements in glycemic response and body weight compared with those assigned the currently approved dose of 1.5 mg weekly, with no new safety signals observed, according to findings from the AWARD-11 trial published in the Journal of the Endocrine Society.

Adults with obesity who wore a heavyweight vest — corresponding to 11% of their body weight — daily for 3 weeks experienced a reduction in body weight and fat mass compared with similar adults who wore a 1% lightweight vest, according to data from a proof-of-concept study.

Adults with overweight or obesity and very poor baseline physical fitness lost less body weight during an 18-month behavioral weight loss intervention compared with those who had poor or better baseline physical fitness levels, according to findings accepted for presentation at the Endocrine Society Annual Meeting.

After undergoing 1 year of gender-affirming hormone therapy, transgender men appear to experience increased insulin sensitivity whereas insulin sensitivity tends to decrease for transgender women, according to findings published in Diabetes Care.

An oral chemotherapy treatment used to treat myeloproliferative neoplasms is associated with substantial weight gain and increased systolic blood pressure, according to findings from a real-world analysis published in Scientific Reports.

Oral semaglutide was shown to be superior to placebo for lowering HbA1c and body weight among adults with type 2 diabetes already taking insulin with or without metformin, according to findings published in Diabetes Care.

Body fat mass — but not nonfat mass — was a causal risk factor for depression, indicating that fat drives the observed BMI-depression causality, according to data from a Mendelian randomization study.

HOUSTON — In this video exclusive, Asha Brown, founder and executive director of We Are Diabetes, speaks with Endocrine Today Diabetes in Real Life columnist Susan Weiner, MS, RDN, CDE, FAADE, about eating disorders and how they manifest among people with type 1 diabetes.